BlackRock Finance, Inc. - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 216 filers reported holding GENMAB A/S in Q2 2024. The put-call ratio across all filers is 4.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of GENMAB A/S
ValueSharesWeighting
Q2 2024$127,674,528
-15.8%
5,080,562
+0.3%
0.00%
-25.0%
Q1 2024$151,557,954
+7.9%
5,067,133
+14.9%
0.00%0.0%
Q4 2023$140,400,861
-17.4%
4,409,575
-8.5%
0.00%
-20.0%
Q3 2023$169,910,365
-14.1%
4,817,419
-7.4%
0.01%0.0%
Q2 2023$197,823,270
-0.2%
5,204,506
-0.8%
0.01%
-16.7%
Q1 2023$198,159,192
-14.6%
5,247,860
-4.2%
0.01%
-14.3%
Q4 2022$232,074,781
+37.1%
5,476,045
+3.9%
0.01%
+16.7%
Q3 2022$169,321,000
-4.3%
5,269,859
-3.2%
0.01%0.0%
Q2 2022$176,900,000
-11.0%
5,444,763
-0.9%
0.01%
+20.0%
Q1 2022$198,799,000
-7.1%
5,494,689
+1.6%
0.01%0.0%
Q4 2021$213,944,000
-28.6%
5,408,118
-21.1%
0.01%
-37.5%
Q3 2021$299,561,000
-4.6%
6,854,964
-10.8%
0.01%
-11.1%
Q2 2021$313,908,000
+126.3%
7,688,152
+81.9%
0.01%
+125.0%
Q1 2021$138,736,000
-6.0%
4,225,884
+16.5%
0.00%
-20.0%
Q4 2020$147,522,000
+10.8%
3,628,193
-0.2%
0.01%0.0%
Q3 2020$133,130,000
+18.4%
3,636,437
+9.6%
0.01%
+25.0%
Q2 2020$112,454,000
+115.4%
3,318,207
+34.7%
0.00%
+33.3%
Q1 2020$52,196,000
+25.4%
2,463,190
+32.1%
0.00%
+50.0%
Q4 2019$41,632,000
+35.3%
1,864,405
+22.8%
0.00%
+100.0%
Q3 2019$30,762,0001,518,3550.00%
Other shareholders
GENMAB A/S shareholders Q2 2024
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 119,681$4,330,0001.29%
Hardman Johnston Global Advisors LLC 982,087$35,532,0001.14%
Aquilo Capital Management, LLC 167,500$6,060,0000.89%
TORRAY INVESTMENT PARTNERS LLC 133,172$4,818,0000.77%
Lester Murray Antman dba SimplyRich 50,044$1,810,0000.63%
First Light Asset Management, LLC 161,913$5,858,0000.52%
Rokos Capital Management LLP 28,565$10,531,0000.49%
Yorktown Management & Research Co Inc 10,100$365,0000.31%
Quantamental Technologies LLC 12,461$451,0000.26%
AZZAD ASSET MANAGEMENT INC /ADV 47,281$1,710,6400.25%
View complete list of GENMAB A/S shareholders